Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.67 | 13.46 |
| PEG Ratio (TTM) | -0.59 | -8.68 |
| P/S Ratio (TTM) | 1.30 | 2.41 |
| P/B Ratio (TTM) | 1.21 | 1.43 |
| P/FCF Ratio (TTM) | 8.52 | -0.05 |
| Price to 5YR AVG Earnings Ratio | 7.62 | 21.96 |
| Price to 5YR AVG FCF Ratio | 1.96 | 16.71 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.41% | 0.93% |
| ROE (TTM) | 7.22% | 11.16% |
| Net Profit Margin (TTM) | 7.81% | 19.12% |
| ROIC 5YR AVG | 9.35% | 18.89% |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -30.35% | 8.30% | 1.34% |
| Revenue | 29.35% | 3.21% | 6.71% |
| Net Income | -29.56% | 8.58% | 1.90% |
| Cash Flow | 9.13% | 28,150.81% | 16,832.49% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.48 | 1.63 |
| Quick Ratio (TTM) | 0.52 | 1.85 |
| D/E Ratio (TTM) | 2.16 | 2.32 |
| Interest Coverage (TTM) | 0.09 | 0.66 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | N/A | 0.33 |
| LTL to 5YR AVG FCF | 3.17 | 13.82 |
| Shares Outstanding Growth 5YR AVG | -0.14% | -1.07% |